Ying Jun Cao
Overview
Explore the profile of Ying Jun Cao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
102
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cao Y, Sawamoto T, Valluri U, Cho K, Lewand M, Swan S, et al.
Clin Pharmacol Drug Dev
. 2016 May;
5(6):435-449.
PMID: 27162173
Two randomized, double-blind, placebo-controlled studies are reported that had the objective to evaluate the pharmacokinetics, pharmacodynamics, and safety of ASP015K (peficitinib), a Janus kinase (JAK) inhibitor, in healthy subjects. The...
2.
Louissaint N, Fuchs E, Bakshi R, Nimmagadda S, Du Y, Macura K, et al.
J Infect Dis
. 2012 Jan;
205(5):725-32.
PMID: 22279121
Background: Rational development of drugs to prevent human immunodeficiency virus (HIV) transmission benefits from an understanding HIV distribution in the female genital tract after intercourse. This study describes HIV distribution...
3.
4.
Xie H, Cao Y, Gauda E, Agthe A, Hendrix C, Lee H
J Clin Pharmacol
. 2010 May;
51(4):502-11.
PMID: 20484620
The population pharmacokinetic (PK) profile of oral clonidine was characterized in newborns with neonatal abstinence syndrome, and significant covariates affecting its PK parameters were identified. Plasma clonidine concentration data were...
5.
Hendrix C, Cao Y, Fuchs E
Annu Rev Pharmacol Toxicol
. 2008 Nov;
49:349-75.
PMID: 19006450
Microbicides, substances applied topically to prevent sexual HIV infection, are needed to empower receptive sexual partners with effective prevention methods. Several large microbicide trials, however, failed to demonstrate efficacy, thus...
6.
Cao Y, Flexner C, Dunaway S, Park J, Klingman K, Wiggins I, et al.
Antimicrob Agents Chemother
. 2008 Feb;
52(5):1630-4.
PMID: 18285477
AMD070, a CXCR4 antagonist, has demonstrated antiretroviral activity in human immunodeficiency virus-infected patients. Since AMD070 is a substrate of cytochrome P450 3A4 and P-glycoprotein, both of which may be affected...